Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis
Ning Jin, Yiyu Qian, Xiao-Fei Jiao, et al.
Redox Biology (2025) Vol. 80, pp. 103528-103528
Open Access | Times Cited: 1
PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF–caspase 8–GSDMD/E axis in ovarian cancer
Yu Xia, Pu Huang, Yiyu Qian, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009032-e009032
Open Access | Times Cited: 7
CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy
Biao Zhang, Jinming Liu, Yuying Mo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
Shini Liu, Peng Deng, Zhaoliang Yu, et al.
Advanced Science (2024) Vol. 11, Iss. 45
Open Access | Times Cited: 4
Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
Yuanjia Wen, Yu Xia, Xiang‐Ping Yang, et al.
Trends in Immunology (2025)
Closed Access
Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors
Pengcheng Lei, Yu‐Hang Yan, Yingying Jiang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Comprehensive dataset of interactors for the entire PARP family using TurboID proximity labeling
Jiefu Zheng, Yawen Deng, Cong Fang, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access
An automatic annotation tool and reference database for T cell subtypes and states at single-cell resolution
Wen‐Kang Shen, Chuyu Zhang, Y. T. Gu, et al.
Science Bulletin (2025)
Open Access
Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids
Qi Cao, Chunhui Cai, Chen Wang, et al.
Phytomedicine (2025) Vol. 141, pp. 156721-156721
Closed Access
PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor
Siyuan Wang, Yu Xia, Yiyu Qian, et al.
Drug Resistance Updates (2025), pp. 101247-101247
Closed Access
Disrupting Cdc42 Activation-Driven Filopodia Formation with Low-Intensity Ultrasound and Microbubbles: A Novel Strategy to Block Ovarian Cancer Metastasis
Xiaoying Li, Chalet Tan, Xiuxiu Fu, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 253, pp. 114724-114724
Closed Access
Homologous Recombination Deficiency Among Patients with Germline or Somatic non-BRCA1/2 Homologous Recombination Repair Gene Variations
Yue Li, Xinhua Yang, Haoyang Cai, et al.
(2025)
Closed Access
Improving regulatory T cell-based therapy: insights into post-translational modification regulation
Aiting Wang, Yanwen Wang, Rui Liang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2024)
Closed Access | Times Cited: 2
Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes
Wen Gao, Hui Yuan, Sheng Yin, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer
Weiwei Gong, Mingqin Kuang, Hongxi Chen, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
CD19+CD73+ B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer
Yawei Zhang, Wendong Wang, Qi Liu, et al.
International Immunopharmacology (2024) Vol. 141, pp. 113002-113002
Closed Access
Harnessing immune cells to leverage PARP inhibitors
Tian‐Li Wang, Ie‐Ming Shih
Cell (2024) Vol. 187, Iss. 18, pp. 4829-4830
Closed Access
Advancing clinical-basic-clinical research: exploring novel immunotargets for ovarian cancer
Yuanzhuo Gu, Long Zhang, Weiguo Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top